Apyx Medical Corporation APYX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Oem | $1.76M-28.4% | $2.45M+35.4% | $1.81M+6.4% | $1.7M+10.4% | $1.54M-27.3% | |
| Surgical Aesthetics | $10.73M— | —— | $11.07M— | —— | $7.89M— | |
| Other Operating Income Expense Net by Business | ||||||
| Oem | $0— | $0— | $0— | —— | —— | |
| Surgical Aesthetics | $0— | —— | $0— | —— | —— | |
| Gross Profit by Business | ||||||
| Oem | $451K-50.7% | $915K+36.6% | $670K+262% | $185K+88.8% | $98K-76.2% | |
| Surgical Aesthetics | $7.47M— | —— | $7.63M— | —— | $5.57M— | |
| Profit Loss by Business | ||||||
| Oem | $443K-51.6% | $915K+37.2% | $667K+269% | $181K+96.7% | $92K-77.4% | |
| Surgical Aesthetics | $1.99M— | —— | $1.9M— | —— | $15K— | |
| Operating Income by Business | ||||||
| Oem | $443K-51.6% | $915K+37.2% | $667K+269% | $181K+96.7% | $92K-77.4% | |
| Surgical Aesthetics | $1.99M— | —— | $1.9M— | —— | $15K— | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business | ||||||
| Oem | $443K-51.6% | $915K+37.2% | $667K+269% | $181K+96.7% | $92K-77.4% | |
| Surgical Aesthetics | $1.99M— | —— | $1.9M— | —— | $15K— | |
| Income Tax Expense Benefit by Business | ||||||
| Oem | $0— | $0— | $0— | $0— | $0— | |
| Surgical Aesthetics | $0— | —— | $0— | —— | $0— | |
| Interest Expense Nonoperating by Business | ||||||
| Oem | -$0— | $0— | -$0— | -$0— | -$0— | |
| Surgical Aesthetics | -$0— | —— | -$0— | —— | -$0— | |
| Cost of Goods Sold by Business | ||||||
| Oem | $1.31M-15.2% | $1.54M+34.8% | $1.14M-24.8% | $1.52M+5.1% | $1.45M-15.5% | |
| Surgical Aesthetics | $3.26M— | —— | $3.44M— | —— | $2.32M— | |
| Investment Income Interest by Business | ||||||
| Oem | $0— | $0— | $0— | $0— | $0— | |
| Surgical Aesthetics | $0— | —— | $0— | —— | $0— | |
| Other Expenses by Business | ||||||
| Oem | $8K— | $0-100% | $3K-25.0% | $4K-33.3% | $6K+20.0% | |
| Surgical Aesthetics | $4.42M— | —— | $4.48M— | —— | $4.71M— | |
| Sales Commissions And Fees by Business | ||||||
| Oem | $0— | $0— | $0— | $0— | $0— | |
| Surgical Aesthetics | $1.07M— | —— | $1.26M— | —— | $839K— | |
| Revenue by Geography | ||||||
| Non Us | $4.38M+3.9% | $4.21M+18.9% | $3.55M-1.4% | $3.6M+33.9% | $2.69M-26.6% | |
| US | $8.11M-45.7% | $14.95M+60.2% | $9.33M+20.0% | $7.78M+15.3% | $6.74M-36.2% | |
| Non-Current Assets by Geography | ||||||
| Non Us | $916K-8.7% | $1M-5.7% | $1.06M+3.0% | $1.03M-6.7% | $1.11M-8.2% | |
| US | $5.43M-3.2% | $5.61M-1.5% | $5.7M+3.3% | $5.52M+1.6% | $5.43M-1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Apyx Medical Corporation break its business down?
- Apyx Medical Corporation (APYX) reports revenue by business across 2 parts — Oem and Surgical Aesthetics. Each is extracted from the segment footnotes and tracked over time.
- Where does Apyx Medical Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Apyx Medical Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
